Jodas Expoim Pvt. Ltd.
Anand Vijaywargia, a Chartered Accountant, has a robust background as a financial leader in various industries. With experience as the Group Chief Financial Officer at multiple companies including Jodas Expoim Pvt Ltd and Glochem Industries Ltd, Anand has also held leadership roles in finance and accounts at Rainbow Children's Hospitals and Wockhardt Hospitals Ltd & Fortis Hospitals Ltd. Prior to this, Anand served as the Manager Finance Accounts & Commercial at KEC International Ltd. In addition, Anand was a Senior Consultant at Shah Chari & Company.
This person is not in any offices
Jodas Expoim Pvt. Ltd.
Jodas is a global, specialty, innovation-driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2008 in India, and today Jodas is a modern, research-driven organization that has quality and affordability at the heart of its activities. Our Core Therapeutic Segments: Anti Infectives (Injectables) Anti Cancer (Injectables & Orals) Contrast Media – Injectables Critical Care (Injectables & Orals) Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective, and affordable generic formulations to the market, touching millions of lives with good health. Jodas has approved products in 30+ countries with State-of-the-art world-class manufacturing facilities and has successfully commercialized 19.4 million Injectables in the year 2022, with unparalleled customer satisfaction. The future endeavor is to be a Global generic player, validating our commitment “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with specialty generic formulations of uncompromising quality.